Skip to main content

IVF

0
Pipeline Programs
5
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Guerbet
GuerbetFrance - Villepinte
1 program
Lipiodol® uterine treatment prior to IVF/ICSIN/A1 trial
Active Trials
NCT06563908Not Yet Recruiting784Est. Dec 2026
Integrated Biosciences
Integrated BiosciencesCA - San Carlos
1 program
estradiol plus progesterone 100 mg IM injectionN/A1 trial
Active Trials
NCT01790282Completed220Est. Mar 2015
One Biosciences
One BiosciencesFrance - Paris
1 program
17-beta estradiolPHASE_21 trial
Active Trials
NCT02677259UnknownEst. Jun 2018
Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
1 program
Combination therapy : Follitropin delta and HP-hMGPHASE_21 trial
Active Trials
NCT06997900Recruiting200Est. Aug 2027
Gedeon Richter
Gedeon RichterHungary - Budapest
1 program
Letrozole 5 mgPHASE_21 trial
Active Trials
NCT04524026Completed25Est. Nov 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Ferring PharmaceuticalsCombination therapy : Follitropin delta and HP-hMG
Gedeon RichterLetrozole 5 mg
One Biosciences17-beta estradiol
GuerbetLipiodol® uterine treatment prior to IVF/ICSI
Integrated Biosciencesestradiol plus progesterone 100 mg IM injection

Clinical Trials (5)

Total enrollment: 1,229 patients across 5 trials

NCT06997900Ferring PharmaceuticalsCombination therapy : Follitropin delta and HP-hMG

Menopur And Rekovelle Combination Study Version 2.0

Start: Jul 2025Est. completion: Aug 2027200 patients
Phase 2Recruiting
NCT04524026Gedeon RichterLetrozole 5 mg

RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2

Start: Sep 2018Est. completion: Nov 202025 patients
Phase 2Completed
NCT02677259One Biosciences17-beta estradiol

Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles

Start: May 2016Est. completion: Jun 2018
Phase 2Unknown
NCT06563908GuerbetLipiodol® uterine treatment prior to IVF/ICSI

Lipiodol Prior to FET (LIFE)

Start: Aug 2024Est. completion: Dec 2026784 patients
N/ANot Yet Recruiting
NCT01790282Integrated Biosciencesestradiol plus progesterone 100 mg IM injection

Is Adding E2 to P4 Luteal Support In High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Outcome? RCT

Start: Mar 2013Est. completion: Mar 2015220 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,229 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.